Safety of abacavir therapy after temporary interruptions in patients without hypersensitivity reactions to the drug.
Berenguer
Juan
J
Padilla
Belén
B
Estrada
Vicente
V
Martín
Carlos
C
Domingo
Pere
P
Kindelán
José María
JM
Ruiz-Giardin
José María
JM
Ruiz-Guiardin
José María
JM
D000328:Adult; D015224:Dideoxynucleosides / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D000099227:Abacavir
D015224:Dideoxynucleosides; D000099227:Abacavir